Enfusion Q3 2023 Earnings Report
Key Takeaways
Enfusion reported a strong Q3 2023, with revenue of $44.4 million, a 13.3% year-over-year growth. The company exceeded expectations and demonstrated the durability of its model, improving Adjusted EBITDA margins. They launched Portfolio WorkBench, expanded EBITDA margin, generated strong free cash flow, and signed new large clients.
Launched the Portfolio WorkBench, empowering portfolio managers to customize and adapt their portfolios.
Significantly expanded EBITDA margin compared to the same period a year ago, reflecting ability to balance investments to drive growth while improving profitability.
Generated strong free cash flow, representing a significant conversion rate.
Reported healthy client add counts, bookings, and ACV, winning larger investment managers.
Enfusion
Enfusion
Enfusion Revenue by Segment
Forward Guidance
No specific forward guidance was provided in the document.
Revenue & Expenses
Visualization of income flow from segment revenue to net income